Low-Dose Recombinant Activated Factor VII (rF-VIIa) for Excess Hemorrhage After Cardiac Operation

Ann Thorac Surg. 2015 May;99(5):1870. doi: 10.1016/j.athoracsur.2014.12.018.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiac Surgical Procedures / mortality*
  • Factor VIIa / adverse effects*
  • Female
  • Humans
  • Male

Substances

  • Factor VIIa